Pharma brand revitalisation in 2026 demands bold shifts: target untapped rural markets, prioritise high-growth brands, optimise P&L, leverage digital channels, and design efficient routes-to-market for sustained growth.

Optimize pharma P&L in India by leveraging nine operational levers: SKU rationalization, expiry management, gross margin focus, working capital efficiency, inventory control, strategic pricing, and trade promotion ROI for sustainable growth.